Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity | GenomeWeb

NEW YORK (GenomeWeb) — Though the reported specificity of sequencing-based non invasive prenatal screening tests is generally more than 99 percent, this doesn't mean that false positive rates will be below one percent for all the disorders these tests now target. In fact, depending on the abnormality in question and the gestational age of a fetus, false positive rates could be as much as 50 percent or more, according to recently published research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.